Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2021

17.08.2020

3.0 T magnetic resonance imaging scanning on different body regions in patients with pacemakers

verfasst von: Xiaohui Ning, Xiaofei Li, Xiaohan Fan, Keping Chen, Wei Hua, Zhimin Liu, Yan Dai, Xiuyu Chen, Minjie Lu, Shihua Zhao, Shu Zhang

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Magnetic resonance imaging (MRI) at 3.0 T is becoming more common, but there is a lack of sufficient evidence on the safety of a 3.0 T scan in patients with pacemakers. This study aimed to investigate the safety and practical concerns of 3.0 T scans for patients with MR-conditional pacemakers.

Methods

Twenty consecutive patients were enrolled. A standardized protocol was developed by cardiologists, pacemaker engineers, and radiologists. Pacemaker interrogation was performed immediately before and after the scan. Scan-related adverse events were documented, and imaging quality was graded as level 1 to 4 by radiologists.

Results

Twenty-three MRI scans of different body regions (brain = 13, lumbar spine = 4, cervical spine = 2, and heart = 4) were performed, and the average time of a scan was 25 ± 11 min. No significant changes in sensing amplitude (atrial 3.1 ± 1.1 mV vs. 2.9 ± 1.2 mV, P = 0.71; ventricular 9.3 ± 3.5 mV vs. 10.2 ± 3.4 mV, P = 0.46), lead impedances (atrial 647 ± 146 Ω vs. 627 ± 151 Ω, P = 0.7; ventricular: 780 ± 247 Ω vs.711 ± 226 Ω, P = 0.36), or pacing threshold (atrial 0.6 ± 0.2 V/0.4 ms vs. 0.6 ± 0.2 V/0.4 ms, P = 0.71; ventricular 0.7 ± 0.3 V/0.4 ms vs. 0.7 ± 0.2 V/0.4 ms, P = 0.85) were observed pre- and postscan. No adverse events were detected. Image quality review showed grade 1 quality in 16 patients and grade 2 quality in 4 patients with artifacts of pulse generators and leads in cardiac MRI scan and no impact on diagnostic value.

Conclusion

Our initial data indicated that 3.0 T scanning might be feasible under a standardized protocol with good diagnostic imaging quality irrespective of body region in patients with MR-conditional pacemakers.
Literatur
1.
Zurück zum Zitat Wood R, Bassett K, Foerster T, Spry C, Tong L. 1.5 tesla magnetic resonance imaging scanners compared with 3.0 tesla magnetic resonance imaging scanners: systematic review of clinical effectiveness. CADTH Technol Overv. 2012;2(2):e2201.PubMedPubMedCentral Wood R, Bassett K, Foerster T, Spry C, Tong L. 1.5 tesla magnetic resonance imaging scanners compared with 3.0 tesla magnetic resonance imaging scanners: systematic review of clinical effectiveness. CADTH Technol Overv. 2012;2(2):e2201.PubMedPubMedCentral
2.
Zurück zum Zitat Soher BJ, Dale BM, Merkle EM. A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am. 2007;15(3):277–90 v.CrossRef Soher BJ, Dale BM, Merkle EM. A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am. 2007;15(3):277–90 v.CrossRef
3.
Zurück zum Zitat Willinek WA, Born M, Simon B, Tschampa HJ, Krautmacher C, Gieseke J, et al. Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging--initial experience. Radiology. 2003;229(3):913–20.CrossRef Willinek WA, Born M, Simon B, Tschampa HJ, Krautmacher C, Gieseke J, et al. Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging--initial experience. Radiology. 2003;229(3):913–20.CrossRef
4.
Zurück zum Zitat van Dijk VF, Delnoy P, Smit JJJ, et al. Preliminary findings on the safety of 1.5 and 3 tesla magnetic resonance imaging in cardiac pacemaker patients. J Cardiovasc Electrophysiol. 2017;28(7):806–10.CrossRef van Dijk VF, Delnoy P, Smit JJJ, et al. Preliminary findings on the safety of 1.5 and 3 tesla magnetic resonance imaging in cardiac pacemaker patients. J Cardiovasc Electrophysiol. 2017;28(7):806–10.CrossRef
5.
Zurück zum Zitat Gimbel JR. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. Pacing Clin Electrophysiol. 2008;31(7):795–801.CrossRef Gimbel JR. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. Pacing Clin Electrophysiol. 2008;31(7):795–801.CrossRef
6.
Zurück zum Zitat Bhuva AN, Moralee R, Moon JC, Manisty CH. Making MRI available for patients with cardiac implantable electronic devices: growing need and barriers to change. Eur Radiol. 2020;30(3):1378–84.CrossRef Bhuva AN, Moralee R, Moon JC, Manisty CH. Making MRI available for patients with cardiac implantable electronic devices: growing need and barriers to change. Eur Radiol. 2020;30(3):1378–84.CrossRef
7.
Zurück zum Zitat Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD, et al. HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14(7):e97–e153.CrossRef Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD, et al. HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14(7):e97–e153.CrossRef
8.
Zurück zum Zitat Bailey WM, Mazur A, McCotter C, Woodard PK, Rosenthal L, Johnson W, et al. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions. Heart Rhythm. 2016;13(2):464–71.CrossRef Bailey WM, Mazur A, McCotter C, Woodard PK, Rosenthal L, Johnson W, et al. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions. Heart Rhythm. 2016;13(2):464–71.CrossRef
9.
Zurück zum Zitat Celentano E, Caccavo V, Santamaria M, Baiocchi C, Melissano D, Pisanò E, et al. Access to magnetic resonance imaging of patients with magnetic resonance-conditional pacemaker and implantable cardioverter-defibrillator systems: results from the really ProMRI study. Europace. 2018;20(6):1001–9.CrossRef Celentano E, Caccavo V, Santamaria M, Baiocchi C, Melissano D, Pisanò E, et al. Access to magnetic resonance imaging of patients with magnetic resonance-conditional pacemaker and implantable cardioverter-defibrillator systems: results from the really ProMRI study. Europace. 2018;20(6):1001–9.CrossRef
10.
Zurück zum Zitat Williamson BD, Gohn DC, Ramza BM, Singh B, Zhong Y, Li S, et al. Real-world evaluation of magnetic resonance imaging in patients with a magnetic resonance imaging conditional pacemaker system: results of 4-year prospective follow-up in 2,629 patients. JACC Clin Electrophysiol. 2017;3(11):1231–9.CrossRef Williamson BD, Gohn DC, Ramza BM, Singh B, Zhong Y, Li S, et al. Real-world evaluation of magnetic resonance imaging in patients with a magnetic resonance imaging conditional pacemaker system: results of 4-year prospective follow-up in 2,629 patients. JACC Clin Electrophysiol. 2017;3(11):1231–9.CrossRef
11.
Zurück zum Zitat Gold MR, Sommer T, Schwitter J, al Fagih A, Albert T, Merkely B, et al. Full-body MRI in patients with an implantable Cardioverter-defibrillator: primary results of a randomized study. J Am Coll Cardiol. 2015;65(24):2581–8.CrossRef Gold MR, Sommer T, Schwitter J, al Fagih A, Albert T, Merkely B, et al. Full-body MRI in patients with an implantable Cardioverter-defibrillator: primary results of a randomized study. J Am Coll Cardiol. 2015;65(24):2581–8.CrossRef
12.
Zurück zum Zitat Awad K, Griffin J, Crawford TC, Lane Cox S, Ferrick K, Mazur A, et al. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions. Heart Rhythm. 2015;12(10):2155–61.CrossRef Awad K, Griffin J, Crawford TC, Lane Cox S, Ferrick K, Mazur A, et al. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions. Heart Rhythm. 2015;12(10):2155–61.CrossRef
13.
Zurück zum Zitat Naehle CP, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H, et al. Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology. 2008;249(3):991–1001.CrossRef Naehle CP, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H, et al. Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology. 2008;249(3):991–1001.CrossRef
14.
Zurück zum Zitat Wilkoff BL, Albert T, Lazebnik M, Park SM, Edmonson J, Herberg B, et al. Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modeling. Heart Rhythm. 2013;10(12):1815–21.CrossRef Wilkoff BL, Albert T, Lazebnik M, Park SM, Edmonson J, Herberg B, et al. Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modeling. Heart Rhythm. 2013;10(12):1815–21.CrossRef
15.
Zurück zum Zitat Dixit N, Stang PP, Pauly JM, Scott GC. Thermo-acoustic ultrasound for detection of RF-induced device Lead heating in MRI. IEEE Trans Med Imaging. 2018;37(2):536–46.CrossRef Dixit N, Stang PP, Pauly JM, Scott GC. Thermo-acoustic ultrasound for detection of RF-induced device Lead heating in MRI. IEEE Trans Med Imaging. 2018;37(2):536–46.CrossRef
16.
Zurück zum Zitat Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace. 2010;12(7):947–51.CrossRef Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace. 2010;12(7):947–51.CrossRef
17.
Zurück zum Zitat Baker KB, Tkach JA, Nyenhuis JA, Phillips M, Shellock FG, Gonzalez-Martinez J, et al. Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating. J Magn Reson Imaging. 2004;20(2):315–20.CrossRef Baker KB, Tkach JA, Nyenhuis JA, Phillips M, Shellock FG, Gonzalez-Martinez J, et al. Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating. J Magn Reson Imaging. 2004;20(2):315–20.CrossRef
18.
Zurück zum Zitat Nazarian S, Hansford R, Rahsepar AA, Weltin V, McVeigh D, Gucuk Ipek E, et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med. 2017;377(26):2555–64.CrossRef Nazarian S, Hansford R, Rahsepar AA, Weltin V, McVeigh D, Gucuk Ipek E, et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med. 2017;377(26):2555–64.CrossRef
19.
Zurück zum Zitat Seewoster T, Lobe S, Hilbert S, et al. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience. Europace. 2019;21:1220–8.CrossRef Seewoster T, Lobe S, Hilbert S, et al. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience. Europace. 2019;21:1220–8.CrossRef
20.
Zurück zum Zitat Sasaki T, Hansford R, Zviman MM, Kolandaivelu A, Bluemke DA, Berger RD, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc Imaging. 2011;4(6):662–70.CrossRef Sasaki T, Hansford R, Zviman MM, Kolandaivelu A, Bluemke DA, Berger RD, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc Imaging. 2011;4(6):662–70.CrossRef
21.
Zurück zum Zitat Raphael CE, Vassiliou V, Alpendurada F, Prasad SK, Pennell DJ, Mohiaddin RH. Clinical value of cardiovascular magnetic resonance in patients with MR-conditional pacemakers. Eur Heart J Cardiovasc Imaging. 2016;17(10):1178–85.CrossRef Raphael CE, Vassiliou V, Alpendurada F, Prasad SK, Pennell DJ, Mohiaddin RH. Clinical value of cardiovascular magnetic resonance in patients with MR-conditional pacemakers. Eur Heart J Cardiovasc Imaging. 2016;17(10):1178–85.CrossRef
Metadaten
Titel
3.0 T magnetic resonance imaging scanning on different body regions in patients with pacemakers
verfasst von
Xiaohui Ning
Xiaofei Li
Xiaohan Fan
Keping Chen
Wei Hua
Zhimin Liu
Yan Dai
Xiuyu Chen
Minjie Lu
Shihua Zhao
Shu Zhang
Publikationsdatum
17.08.2020
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2021
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-020-00854-3

Weitere Artikel der Ausgabe 3/2021

Journal of Interventional Cardiac Electrophysiology 3/2021 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.